A Study of MCARH109 and MCARH125 in People With Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
Scientists will collect T cells from people and turn them into two treatments called MCARH109 and MCARH125. Some people will get only MCARH125 and others will get MCARH125 along with MCARH109.
Scientists will collect T cells from people and turn them into two treatments called MCARH109 and MCARH125. Some people will get only MCARH125 and others will get MCARH125 along with MCARH109.
*Third Opinion AI Generated Synopsis
Trial Summary
A sample of participants' T cells will be sent to a laboratory, where the cells will be made into the study therapy, MCARH109 and MCARH125. Participants will receive either MCARH125 alone or MCARH125 with MCARH109.
A sample of participants' T cells will be sent to a laboratory, where the cells will be made into the study therapy, MCARH109 and MCARH125. Participants will receive either MCARH125 alone or MCARH125 with MCARH109.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: